Cinctive Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.81M | Buy |
138,040
+94,645
| +218% | +$1.93M | 0.15% | 173 |
|
|
2025
Q1 | $788K | Sell |
43,395
-37,925
| -47% | -$688K | 0.06% | 224 |
|
|
2024
Q4 | $2.05M | Buy |
81,320
+47,523
| +141% | +$1.2M | 0.1% | 206 |
|
|
2024
Q3 | $1.15M | Sell |
33,797
-57,330
| -63% | -$1.95M | 0.06% | 265 |
|
|
2024
Q2 | $3.37M | Buy |
91,127
+22,646
| +33% | +$838K | 0.16% | 173 |
|
|
2024
Q1 | $2.87M | Buy |
+68,481
| New | +$2.87M | 0.13% | 175 |
|